Last updated on April 23, 2014 at 16:13 EDT

Nouveau Life Pharmaceuticals (NOUV) CEO Provides Update for Shareholders

July 9, 2012

FORT LAUDERDALE, Fla., July 9, 2012 /PRNewswire/ — The CEO of Nouveau Life Pharmaceuticals, Inc. (Pink Sheets: NOUV), Melissa Walker, today provided a Company update for Shareholders. Nouveau Life Pharmaceuticals is a provider of quality, all-natural dietary supplements.

“Nouveau Life currently has four products in production that target the Boomer population: Glucosamine Sulfate, Krill Oil, Vitamins A&D, and Calcium with Vitamin D. It looks like the first of these products will be available to release to the public this week. With the addition of these products, Nouveau will have a total of eight supplements on the market. Nouveau’s business plan calls for aggressively and strategically adding products. We continue to analyze the market for the most profitable niches.”

“Sales to date have been better than expected. Nouveau continues to receive orders from around the globe. Our online store at www.nlpnaturals.com went live just over a month ago and the response has been overwhelmingly positive. Our male enhancement supplements Azul: Male Enhancer(TM) and Azul Instant(TM) have been our top sellers; however, the New Life Naturals: For Your Weight Loss(TM) supplement is also showing strong returns. We expect that the launch of our Affiliate Program and partnerships with mass distribution firms will have dramatic effects on revenues.”

“Last week Nouveau Life experienced its first minor hiccup in customer service. Our Azul Instant(TM) supplement is shipped from a distribution center in the Virginia area. Due to the recent storms and subsequent power outages in that region, several customers experienced a delay in receiving their Azul Instant(TM) orders. While we certainly can’t control the weather, we understand that our customers expect quality products coupled with exceptional customer service. We believe that all orders have now been received by our customers; however, our customer service team is working diligently to follow up with all affected customers to remedy the situation.”

“We are running the final tests on our Nouveau Life Affiliate Sales Program. The highly anticipated Affiliate Program should be ready for launch possibly as soon as tomorrow. There are no fees associated with Nouveau’s Affiliate Program, and Affiliate Partners will receive a percentage of all sales they drive to our site at www.nlpnaturals.com. We encourage anyone interested in the Affiliate Program to check the website daily for possible updates. In addition to our Affiliate Sales Program, Nouveau Life is in talks with mass distribution firms in Canada and the UK. Our Canadian contacts are helping us navigate Canadian regulations, and we plan to apply for a dietary supplement license within the next few weeks with the Natural Health Products Directorate, a branch of Health Canada. Canada requires that dietary supplements be licensed prior to market entry.”

About Nouveau Life Pharmaceuticals
The Company, formerly known as Hybrid Fuels, Inc., was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.

Forward-Looking Statements – This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that could cause future results to differ materially from the forward-looking statements. You should consider these factors in evaluating the statements herein, and not rely on such statements. The forward-looking statements in this release are made as of the date hereof and Nouveau Life Pharmaceuticals, Inc. undertakes no obligation to update such statements.

Nouveau Life Pharmaceuticals, Inc. – 954-903-2993

SOURCE Nouveau Life Pharmaceuticals, Inc.

Source: PR Newswire